Cargando…
Chromoblastomycosis: New Perspective on Adjuvant Treatment with Acitretin
Chromoblastomycosis (CBM) is a neglected human disease, caused by different species of pigmented dematiaceous fungi that cause granulomatous and suppurative dermatosis. This infection is difficult to treat and there are limited therapeutic options, including terbinafine, itraconazole, and tioconazol...
Autores principales: | Belda, Walter, Passero, Luiz Felipe Domingues, de Carvalho, Caroline Heleno Chagas, Mojica, Paula Celeste Rubiano, Vale, Pablo Andrade |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660773/ https://www.ncbi.nlm.nih.gov/pubmed/37987273 http://dx.doi.org/10.3390/diseases11040162 |
Ejemplares similares
-
Chromoblastomycosis evolving to sarcomatoid squamous cell carcinoma: A case report
por: Belda Junior, Walter, et al.
Publicado: (2021) -
Reviewing the Etiologic Agents, Microbe-Host Relationship, Immune Response, Diagnosis, and Treatment in Chromoblastomycosis
por: Passero, Luiz Felipe Domingues, et al.
Publicado: (2021) -
Lymphocutaneous Sporotrichosis Refractory to First-Line Treatment
por: Belda, Walter, et al.
Publicado: (2021) -
A case of tuberculosis verrucosa cutis in Brazil undiagnosed for 15 years
por: Wedy, Glaucia Ferreira, et al.
Publicado: (2021) -
Topical Application of Imiquimod as a Treatment for Chromoblastomycosis
por: de Sousa, Maria da Glória Teixeira, et al.
Publicado: (2014)